Top Pharmaceutical Companies in Vancouver (19)
NanoVation Therapeutics is a pioneer in the design and creation of lipid nanoparticles (LNPs) for nucleic acid delivery. The company’s LNP technologies aim to overcome the limits of existing approaches to nucleic acid delivery, including the ability to target tissues outside the liver (extrahepatic delivery). NanoVation’s lead technology is its proprietary long-circulating LNP (lcLNP™) platform, which enables functional nucleic acid delivery...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give...
Jazz Pharmaceuticals, Inc's Top Stability & Growth Strengths
Strong Market Position & Advantage: Jazz is described as a clear leader in rare sleep disorders through its oxybate franchise (Xywav/Xyrem and authorized generics royalties) and in cannabinoid-based epilepsy with Epidiolex surpassing $1B in 2025. Xywav’s idiopathic hypersomnia approval with orphan exclusivity and category-leading revenue reinforce defensibility.
Strong Revenue Growth: Record 2025 revenue around $4.27 billion and a record Q4, with 2026 guidance still pointing up, indicate sustained top-line momentum. Company communications highlight a multi-year streak of annual growth continuing into 2026.
Diversified Revenue Streams: A balanced base with rare sleep revenues above $2B, Epidiolex above $1B, and roughly $1.13B in oncology plus new contributions from Modeyso and royalties shows multiple revenue pillars. Pipeline drivers like zanidatamab and Zepzelca label expansion add additional avenues.
Canada's online pharmacy ?? We make it easy to fill prescriptions ?, consult with pharmacists ?, and order medications online ?. #Pocketpills #PocketpillsPeople
Canopy is a world leading cannabis company focused on unleashing the power of cannabis to improve lives. From supporting personal wellness to fostering economic opportunity and striving towards social justice, Canopy is showcasing the capacity of cannabis as a force for good
Save-On-Foods is a community-focused grocery retailer and pharmacy provider. The company operates a chain of supermarkets offering a wide variety of food and household products, alongside professional pharmacy services. Dedicated to customer service and employee development, Save-On-Foods provides a fast-paced retail environment with a commitment to ongoing training and community engagement across its store locations.
Save-On-Foods's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is the leading full‑service grocer in Western Canada with dense coverage, especially in British Columbia, and serves as the flagship banner within a larger regional food group. Wholesale ties within its parent group extend its influence beyond its own storefronts.
Market Expansion: Store count has trended upward through a mix of net‑new openings, small‑format entries, and conversions across Western Canada, including deeper moves into Saskatchewan, Manitoba, and the Yukon. A visible pipeline and distribution investments indicate continued regional build‑out.
Strong Brand Reputation: It is frequently recognized among B.C.’s most loved brands and is cited for customer service and sustainability leadership, including food‑waste reduction initiatives. Early e‑commerce adoption and community customization bolster its standing in core markets.
Factors Group of Nutritional Companies is a Canadian wellness enterprise focused on researching, developing, manufacturing, and distributing natural health products. Primarily operating under the Natural Factors brand, it produces vitamins, minerals, herbal remedies, extracts, and specialty nutritional supplements. The family-owned company serves consumers across North America and Australia, combining product development with large-scale manufacturing and distribution of tested, trusted health-building...
Bold Therapeutics is the world leader in the development of novel metallotherapeutics. Bold Therapeutics' lead program, BOLD-100, has demonstrated positive safety and efficacy in Phase 2 clinical trials in colorectal, biliary tract and gastric cancers, with presentations at ASCO 2024 and ASCO GI 2024. Bold Therapeutics expects to initiate pivotal Phase 3 trials in the near future.
From scientist features to #ScienceMemes and #SciComm 🧬Free educational videos and resources for Life Sciences🧪 Check out our collection of free learning resources: https://info.abmgood.com/learning-resources Applied Biological Materials (abm) provides quality research reagents and custom services at incredible prices. We have an extensive product range to make abm your one-stop supplier for all your research needs: PCR, RT-PCR, qPCR, antibodies, siRNA, miRNA, CRISPR, stable...
Mednow is a Vancouver, British Columbia-based healthcare technology company and Canada's full-service online pharmacy. It operates a proprietary web and mobile application to facilitate the sale and distribution of prescription medications and provides fast advice from certified pharmacists through a digital-first environment, optimizing delivery through modern digital platforms and last-mile logistics.
WEX Pharmaceuticals Inc. is a late-stage drug development company in Vancouver, Canada dedicated to the research, development, manufacture, and commercialization of Halneuron®, a new novel non-opioid analgesic. Halneuron® is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology: - Non-addictive, no withdrawal symptoms and no euphoria - No build of up of tolerance over time - A long duration of...
IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve...
Variational AI has developed Enki, the biopharma industry's first commercially-available foundation model for small molecules. Enki is based on a novel generative AI framework invented by Variational AI that has delivered novel and selective leads to multiple biopharma partners and customers.
Frontage Laboratories, Inc. is a CRO that provides integrated, science-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies....
Frontage Laboratories, Inc's Top Stability & Growth Strengths
Market Expansion: Recent announcements describe expansion of early‑phase clinical capabilities in 2026 alongside new and enlarged sites in Exton, Pennsylvania and Europe, indicating broader geographic reach and capacity. Acquisitions and a rising backlog/future contracted revenue further point to continuing expansion into additional markets and regions.
Product Line Growth: New GMP CRDMO capacity came online with a 46,300‑sq‑ft facility opened in 2025 and fully validated by late 2025, adding nine GMP suites and related labs. The 2026 acquisition of a CAP‑accredited central lab in China and added early‑phase clinical capabilities broaden the service portfolio.
Strong Revenue Growth: Recent interim results show first‑half 2026 revenue up 17.1% year over year with net profit more than doubling, signaling a rebound from prior softness. Purchase orders/backlog also increased versus prior periods, supporting near‑term top‑line momentum.
Brains Bioceutical Corp is a globally recognized leader in GMP-certified production of naturally-sourced Active Pharmaceutical Ingredients (API). #MadeBetter
Aequus Pharmaceuticals (TSX-V: AQS, OTCQB: AQSZF) is a rapidly growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including neurology, ophthalmology and transplant. Aequus is developing a pipeline of products in neurology and psychiatry with a goal of addressing the need for...
ALS Limited is a global leader in testing, inspection, certification, and verification services, providing comprehensive solutions across industries such as life sciences, minerals, industrial, and energy.
ALS Limited's Top Stability & Growth Strengths
Strong Revenue Growth: Financial results highlight record revenue with double‑digit year‑on‑year increases, supported by organic expansion and acquisitions. Growth has been broad-based across the portfolio with standout momentum in the Commodities division.
Profitability: Earnings expanded faster than sales, with underlying profit and margins rising to new highs. Momentum includes strong EBIT growth and accelerating NPAT alongside ongoing business transformations.
Strong Market Position & Advantage: Positioning as a top‑tier global specialist—especially in minerals and environmental testing—supports commercial resilience. A large international laboratory network and recognized expertise (including PFAS capabilities) underpin competitive strength.
BetterLife is an emerging biotech company focused on developing & commercializing patient-friendly compounds to address the global unmet mental health issues
Established in 2021, the Pattison Food Group is a Jim Pattison business and Western Canada’s leading provider of food and drugs. The Pattison Food Group includes Save-On-Foods, Buy-Low Foods, Quality Foods, Everything Wine, Pure Integrative Pharmacy, Imperial Distributors Canada Inc., More Rewards and other Jim Pattison Group specialty and wholesale operations. Its businesses employ more than 30,000 team members in...
Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. Our lead molecule, azetukalner, is a novel, potent, selective Kv7 potassium channel opener in Phase 3 clinical trials for the treatment of epilepsy, major depressive disorder (MDD) and bipolar depression (BPD). We are also advancing an early-stage portfolio...
